| Bioactivity | DPI-3290 (Org 41793) is a potent and specific opioid receptors agonist with Ki values of 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively。DPI-3290 is one of a series of novel centrally acting agents with potent antinociceptive activity[1]. |
| Target | IC50: 0.18 nM (δ-opioid receptor), 0.46 nM (μ-opioid receptor) and 0.62 nM (κ-opioid receptor) |
| In Vivo | DPI-3290 (Org 41793) (intravenous; 0.05 mg/kg) produces a 50% antinociceptive response in rats[1]. |
| Name | DPI-3290 |
| CAS | 182417-73-8 |
| Formula | C30H34FN3O2 |
| Molar Mass | 487.61 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gengo PJ, et al. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity. J Pharmacol Exp Ther. 2003 Dec;307(3):12 |
DPI-3290
CAS: 182417-73-8 F: C30H34FN3O2 W: 487.61
DPI-3290 (Org 41793) is a potent and specific opioid receptors agonist with Ki values of 0.18 nM, 0.46 nM, and 0.62 nM f
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.